AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)
AAPL 204.61 +0.13 (+0.06%)MSFT 123.75 +0.14 (+0.11%)FB 181.79 +1.28 (+0.71%)ZNGA 5.52 +0.05 (+1.01%)NVDA 188.48 +0.19 (+0.10%)WBA 54.09 -0.26 (-0.48%)GOOG 1248.72 +4.8 (+0.39%)PIH 5.25 -0.05 (-0.94%)

Cash Flow ACHN Quote Achillion P

All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Year 201420152016
NetIncome -62 -85 -70
Depreciation 1 1 1
DeferredIncomeT 0 0 0
StockBasedCompe 11 11 9
AccountsReceiva 0 0 0
InventoryCS 0 0 0
AccountsPayable 3 -2 -3
OtherWorkingCap -15 15 0
OtherNonCashIte -1 -1 0
NetCashProvided -66 -59 -62
InvestmentsInPP -3 -1 -1
AcquisitionsNet 0 0 0
PurchasesOfInve -499 -345 -223
SalesMaturities 562 372 290
PurchasesOfInta 0 0 0
OtherInvestingA 0 0 0
NetCashUsedForI 61 26 66
DebtIssued 0 0 0
DebtRepayment 0 0 0
CommonStockIssu 0 0 0
CommonStockRepu 0 0 0
DividendPaid 0 0 0
OtherFinancingA 0 0 2
NetCashProvided 1 0 2
NetChangeInCash -4 -34 6
CashAtBeginning 82 77 44
CashAtEndOfPeri 77 43 50
Achillion Pharmaceuticals Inc. income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Achillion Pharmaceuticals Inc. FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.